EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma

被引:1
|
作者
Gao X. [1 ]
Yang C. [1 ,2 ,3 ]
Li H. [1 ,2 ,3 ,4 ]
Shao L. [1 ,2 ,4 ]
Wang M. [1 ,2 ,3 ]
Su R. [1 ]
机构
[1] The First Clinical Medical College, Gansu University of Chinese Medicine, Gansu, Lanzhou
[2] Department of Geriatrics, Affiliated Hospital of Gansu University of Chinese Medicine, Gansu, Lanzhou
[3] Key Laboratory of Traditional Chinese Herbs and Prescription Innovation and Transformation of Gansu Province and Gansu Provincial Traditional Chinese Medicine New Product Innovation Engineering Laboratory, Gansu University of Chinese Medicine, Gansu, Lanzh
[4] Key Laboratory of Dunhuang Medicine and Transformation, Ministry of Education, Gansu University of Chinese Medicine, Gansu, Lanzhou
关键词
D O I
10.1038/s41598-023-47886-z
中图分类号
学科分类号
摘要
This study was designed to evaluate the prognosis and pharmacological therapy sensitivity of epithelial mesenchymal transition-related genes (EMTRGs) that obtained from the EMTome database in hepatocellular carcinoma (HCC) using bioinformatical method. The expression status of EMTRGs were also investigated using the clinical information of HCC patients supported by TCGA database and the ICGC database to establish the TCGA cohort as the training set and the ICGC cohort as the validation set. Analyze the EMTRGs between HCC tissue and liver tissue in the TCGA cohort in the order of univariate COX regression, LASSO regression, and multivariate COX regression, and construct a risk model for EMTRGs. In addition, enrichment pathways, gene mutation status, immune infiltration, and response to drugs were also analyzed in the high-risk and low-risk groups of the TCGA cohort, and the protein expression status of EMTRGs was verified. The results showed a total of 286 differentially expressed EMTRGs in the TCGA cohort, and EZH2, S100A9, TNFRSF11B, SPINK5, and CCL21 were used for modeling. The TCGA cohort was found to have a worse outcome in the high-risk group of HCC patients, and the ICGC cohort confirmed this finding. In addition, EMTRGs risk score was shown to be an independent prognostic factor in both cohorts by univariate and multivariate COX regression. The results of GSEA analysis showed that most of the enriched pathways in the high-risk group were associated with tumor, and the pathways enriched in the low-risk group were mainly associated with metabolism. Patients in various risk groups had varying immunological conditions, and the high-risk group might benefit more from targeted treatments. To sum up, the EMTRGs risk model was developed to forecast the prognosis for HCC patients, and the model might be useful in assisting in the choice of treatment drugs for HCC patients. © 2023, The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] EMT-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Hepatocellular Carcinoma
    Cao, Dan
    Liu, Huan
    Bai, Lang
    Tang, Hong
    DIGESTIVE DISEASES, 2023, 41 (02) : 282 - 295
  • [2] Expression levels of EMT-related genes in hepatocellular carcinoma
    Nagai, Tomoyuki
    Arao, Tokuzo
    Matsumoto, Kazuko
    Kudo, Kanae
    Hagiwara, Satoru
    Sakurai, Toshiharu
    Ueshima, Kazuomi
    Haji, Seiji
    Kudo, Masatoshi
    Nishio, Kazuto
    CANCER RESEARCH, 2011, 71
  • [3] Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer
    Li, Song-Chao
    Jia, Zhan-Kui
    Yang, Jin-Jian
    Ning, Xiang-Hui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Establishment and Analysis of an Individualized EMT-Related Gene Signature for the Prognosis of Breast Cancer in Female Patients
    Xue, Wei
    Sun, Chenyu
    Yuan, Hui
    Yang, Xin
    Zhang, Qiuping
    Liao, Yunnuo
    Guo, Hongwei
    DISEASE MARKERS, 2022, 2022
  • [5] An EMT-related gene signature for the prognosis of human bladder cancer
    Cao, Rui
    Yuan, Lushun
    Ma, Bo
    Wang, Gang
    Qiu, Wei
    Tian, Ye
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (01) : 605 - 617
  • [6] Comprehensive analysis of EMT-related genes and lncRNAs in the prognosis, immunity, and drug treatment of colorectal cancer
    Yang Yang
    Mingyang Feng
    LiangLiang Bai
    Weiting Liao
    Kexun Zhou
    Mengxi Zhang
    Qiuji Wu
    Feng Wen
    Wanting Lei
    Pengfei Zhang
    Nan Zhang
    Jiaxing Huang
    Qiu Li
    Journal of Translational Medicine, 19
  • [7] Comprehensive analysis of EMT-related genes and lncRNAs in the prognosis, immunity, and drug treatment of colorectal cancer
    Yang, Yang
    Feng, Mingyang
    Bai, LiangLiang
    Liao, Weiting
    Zhou, Kexun
    Zhang, Mengxi
    Wu, Qiuji
    Wen, Feng
    Lei, Wanting
    Zhang, Pengfei
    Zhang, Nan
    Huang, Jiaxing
    Li, Qiu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [8] EMT-Related Gene Signature Predicts the Prognosis in Uveal Melanoma Patients
    Lv, Yufei
    He, Lixian
    Jin, Mengyi
    Sun, Wenxin
    Tan, Gang
    Liu, Zuguo
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [9] Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular Carcinoma
    Lin Zhu
    Yan Lou
    Qiyu Xiao
    Ling Wang
    Guodong Chen
    Wenjun Yang
    Tengjiao Wang
    Biochemical Genetics, 2024, 62 : 698 - 717
  • [10] Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular Carcinoma
    Zhu, Lin
    Lou, Yan
    Xiao, Qiyu
    Wang, Ling
    Chen, Guodong
    Yang, Wenjun
    Wang, Tengjiao
    BIOCHEMICAL GENETICS, 2024, 62 (02) : 698 - 717